The BioIntelliSense BioButton monitors vital signs in those who have had the COVID-19 vaccine.
Some health care workers in Colorado who have already received the Pfizer COVID-19 vaccine are continuing to help doctors and researchers learn about the coronavirus and how the new vaccine works by participating in a program that watches the side effects of the vaccine.
When they were given the vaccine at the University of Colorado Anschutz Medical Campus, they were given a wearable medical device that tracks their temperature, respiratory rate, and heart rate at rest. The device is about the size of a coin.
This is part of an effort to develop a post-vaccine monitoring program that can be used in higher-risk populations.
BioIntelliSense, Inc., the creators of the device, is a continuous health monitoring and clinical intelligence company that makes the BioIntelliSense BioButton based in Golden, Colorado. Those who are participating in the program were given the device two days before they received the vaccine and will wear them for seven days after.
"The participation of our frontline health care workers in this vaccine monitoring program serves as an important operational milestone in scaling the program for the larger population, particularly with vulnerable patient populations and seniors in long-term care environments," said Dr. Richard Zane, UCHealth chief innovation officer and professor and chair of emergency medicine at the University of Colorado School of Medicine in a press release. "We work closely with partners like BioIntelliSense to not only navigate the ever-changing landscape of health care but collaboratively develop the innovative tools that are transforming the way patients receive care."
The BioIntelliSense BioButton was announced in May 2020 and is the first FDA cleared single-use device that can monitor vital signs for up to 30 days. The company hopes to help a safe return to school, work, and travel and believes this device will help pave the way to that happening. CU Innovations, UCHealth, and its CARE Innovation Center with BioIntelliSense Inc. are working in collaboration to observe clinical applications of the company’s medical devices. BioIntelliSense, Inc has been nominated as a CES 2021 Innovation Awards Honoree for the BioButton.
The BioButton is also being utilized in other places in the country, including Oakland University in Michigan, where it has been utilized to track the vital signs of staff and students since August. The devices transmit information through Bluetooth to an app on the individual's phone. This has been beneficial to the university to help track patients, alert people if they should be tested, and assist with contact tracing for those on campus.
“The vaccine is a significant clinical achievement in addressing the COVID-19 global pandemic,” said James Mault, MD, CEO of BioIntelliSense, Inc. “We are proud to partner with UCHealth in providing our BioIntelliSense medical-grade wearable technology and advanced data services to address high-risk patient populations and to offer peace of mind monitoring for those who may be concerned about receiving the vaccine.”
For more information and to see how the BioButton device works, you can watch an instructional video from the company here.
What do you think about this new technology? Would you participate in a program like this to help better understand the COVID-19 virus and how the vaccine is working? Sound off in the comments.